Exigen Pharmaceuticals, Inc.
Records under this name other than patents Exigen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Exigen Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,989,218 | Protein fragment complementation assays for the detection of biological or drug interactions Lapsed on the fee record Ended Aug 2, 2019 · From the USPTO record | Lapsed on the fee record | Ended Aug 2, 2019 | From the USPTO record |
| US 7,160,691 | Protein fragment complementation assays for the detection of biological or drug interactions Term ended Term ended Oct 14, 2018 · From the USPTO record | Term ended | Term ended Oct 14, 2018 | From the USPTO record |
| US 6,294,330 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Term ended Jul 30, 2018 · From the USPTO record | Term ended | Term ended Jul 30, 2018 | From the USPTO record |
| US 6,270,964 | Protein fragment complementation assays for the detection of biological or drug interactions Formerly held Term ended Term ended Feb 2, 2018 · From the USPTO record | Term ended | Term ended Feb 2, 2018 | From the USPTO record |
| US 6,428,951 | Protein fragment complementation assays for the detection of biological or drug interactions Term ended Ended no later than Feb 2, 2018 · From the USPTO record | Term ended | Ended no later than Feb 2, 2018 | From the USPTO record |
| US 8,192,944 | Protein fragment complementation assays for the detection of biological or drug interactions Term ended Ended no later than Feb 2, 2018 · From the USPTO record | Term ended | Ended no later than Feb 2, 2018 | From the USPTO record |
| US 7,855,167 | In vivo screening of protein-protein interactions with protein-fragment complementation assays Lapsed on the fee record Ended Dec 21, 2014 · From the USPTO record | Lapsed on the fee record | Ended Dec 21, 2014 | From the USPTO record |